选择性单个胚胎转移在体外受精周期中,使用下一代测序进行或不进行植入前遗传测试:一种随机临床试验
Pedro Felipe Magalhães Peregrino1, Carlos Augusto Z Nissel1, Patricia Florido1
1Disciplina de Ginecologia, Departamento de Obstetrícia e Ginecologia, Hospital das Clínicas da Faculdade de Medicina da Faculdade de Medicina da Universidade de São Paulo, São Paulo, SP, Brazil.
Clinics (Sao Paulo, Brazil)
|February 25, 2026
概括
使用下一代测序 (NGS) 的植入前遗传检测 (PGT-A) 不能改善单个胚胎移植的IVF预后良好患者的怀孕率. 这项研究发现,胚胎遗传分析在这个患者群体中没有显著的益处.
科学领域:
- 生殖医学 生殖医学
- 遗传学 是一个遗传学.
- 在体外受精 (IVF)
背景情况:
- 在试管婴儿中,用于胚胎选择,越来越多地使用了预植入性形性遗传检测 (PGT-A).
- 它在良好的预后患者的临床实用性是有争议的,对使用下一代测序 (NGS) 的好处的PGT-A的证据有限.
- 缺乏关于PGT-A (NGS) 对预后良好,接受选择性单胚胎移植 (eSET) 的试管婴儿患者怀孕和活产率的影响的可靠数据.
研究的目的:
- 为了比较具有良好的预后的试管婴儿患者的临床怀孕率,这些患者接受了带有或没有PGT-A (NGS) 的eSET.
主要方法:
- 一项前性随机临床研究,涉及206名患者.
- 患者被随机分为两个组:没有遗传分析的eSET (SET组,n=103) 和使用NGS的PGT-A的eSET (NGS + SET组,n=103).
- 主要终点是第一个胚胎移植后的临床怀孕率.
主要成果:
- 第一次转移后的临床怀孕率在SET组 (76.7%) 和NGS+SET组 (79.6%) (p=0.613) 之间是相似的.
- 两组之间没有观察到活产率或堕胎率的统计学上显著差异.
- 该研究发现,在这个患者群体中,PGT-A (NGS) 治疗结果没有改善.
结论:
- PGT-A (NGS) 没有显著改善受精不孕夫妇的试管婴儿结果,这些夫妇有良好的预后,接受了eSET.
- 在预后良好的试管婴儿患者中,PGT-A (NGS) 的临床实用性仍然值得怀疑.
- 可能需要进一步的研究来确定可能受益于PGT-A.的特定子组.
相关概念视频
In Vitro Fertilization
1.1K
In vitro fertilization (IVF) is a form of assisted reproductive technology where an egg is fertilized with sperm in a controlled laboratory environment before transferring the resulting embryo into the uterus. This process is designed to help individuals and couples experiencing difficulties conceiving.
The IVF process begins with ovarian stimulation, during which reproductive endocrinologists prescribe hormonal medications to stimulate the ovaries to produce multiple eggs instead of the single...
The IVF process begins with ovarian stimulation, during which reproductive endocrinologists prescribe hormonal medications to stimulate the ovaries to produce multiple eggs instead of the single...
1.1K
Next-generation Sequencing
99.5K
The first human genome sequencing project cost $2.7 billion and was declared complete in 2003, after 15 years of international cooperation and collaboration between several research teams and funding agencies. Today, with the advent of next-generation sequencing technologies, the cost and time of sequencing a human genome have dropped over 100 fold.
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features....
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features....
99.5K


